4.59
price up icon2.23%   0.10
after-market アフターアワーズ: 4.61 0.02 +0.44%
loading
前日終値:
$4.49
開ける:
$4.5
24時間の取引高:
4.21M
Relative Volume:
1.32
時価総額:
$1.41B
収益:
$248.37M
当期純損益:
$11.74M
株価収益率:
91.80
EPS:
0.05
ネットキャッシュフロー:
$18.24M
1週間 パフォーマンス:
+11.68%
1か月 パフォーマンス:
+20.16%
6か月 パフォーマンス:
-12.24%
1年 パフォーマンス:
-27.49%
1日の値動き範囲:
Value
$4.50
$4.62
1週間の範囲:
Value
$3.76
$4.62
52週間の値動き範囲:
Value
$3.3812
$7.63

Mannkind Corp Stock (MNKD) Company Profile

Name
名前
Mannkind Corp
Name
セクター
Healthcare (1145)
Name
電話
818-661-5000
Name
住所
1 CASPER STREET, DANBURY, CA
Name
職員
407
Name
Twitter
@MannKindCorp
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
MNKD's Discussions on Twitter

MNKD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MNKD
Mannkind Corp
4.59 1.38B 248.37M 11.74M 18.24M 0.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.02 100.52B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
580.70 61.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
446.51 59.29B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
712.20 43.09B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
306.05 35.42B 3.81B -644.79M -669.77M -6.24

Mannkind Corp Stock (MNKD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-16 再開されました H.C. Wainwright Buy
2025-04-10 開始されました Mizuho Outperform
2025-02-10 開始されました Wedbush Outperform
2024-12-20 開始されました Wells Fargo Overweight
2024-12-19 アップグレード RBC Capital Mkts Sector Perform → Outperform
2024-09-09 再開されました Leerink Partners Outperform
2024-06-13 開始されました Rodman & Renshaw Buy
2023-10-10 開始されました Wedbush Outperform
2021-05-14 開始されました RBC Capital Mkts Sector Perform
2019-12-24 開始されました Oppenheimer Outperform
2019-10-25 開始されました Cantor Fitzgerald Overweight
2019-05-14 開始されました BTIG Research Buy
2019-03-04 開始されました SVB Leerink Outperform
2019-02-22 開始されました SVB Leerink Outperform
2018-02-28 ダウングレード Maxim Group Hold → Sell
2017-11-01 ダウングレード Maxim Group Buy → Hold
2017-10-10 開始されました H.C. Wainwright Buy
2017-10-06 繰り返されました Maxim Group Buy
2017-08-11 開始されました Maxim Group Buy
2016-05-10 繰り返されました Piper Jaffray Underweight
2016-05-10 繰り返されました RBC Capital Mkts Underperform
2016-01-06 繰り返されました Piper Jaffray Underweight
2016-01-06 繰り返されました RBC Capital Mkts Underperform
2015-11-04 ダウングレード RBC Capital Mkts Outperform → Underperform
2015-09-09 ダウングレード Piper Jaffray Neutral → Underweight
2015-08-03 繰り返されました RBC Capital Mkts Outperform
2015-05-11 ダウングレード JP Morgan Neutral → Underweight
2015-05-11 繰り返されました MLV & Co Hold
2015-04-16 繰り返されました RBC Capital Mkts Outperform
すべてを表示

Mannkind Corp (MNKD) 最新ニュース

pulisher
Sep 01, 2025

How MannKind Corporation stock performs during market volatilityTrade Exit Summary & Risk Controlled Stock Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Trend analysis for MannKind Corporation this week2025 Big Picture & Fast Gain Swing Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

How to recover losses in MannKind Corporation stockWall Street Watch & Verified Technical Signals - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Historical volatility pattern of MannKind Corporation visualizedEarnings Growth Report & Smart Investment Allocation Tips - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Can trapped investors hope for a rebound in MannKind Corporation2025 Earnings Surprises & Technical Pattern Recognition Alerts - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Applying chart zones and confluence areas to MannKind CorporationInflation Watch & Safe Entry Point Identification - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Forecasting MannKind Corporation price range with options dataWeekly Risk Report & High Conviction Trade Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What to expect from MannKind Corporation in the next 30 days2025 Major Catalysts & High Yield Equity Trading Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Published on: 2025-08-31 07:53:49 - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

When is the best time to exit MannKind CorporationMarket Sentiment Summary & Safe Entry Zone Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How to integrate MannKind Corporation into portfolio analysis toolsPortfolio Return Summary & Real-Time Buy Signal Notifications - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Applying sector rotation models to MannKind CorporationWeekly Investment Report & Weekly High Conviction Ideas - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

MannKind Corporation stock trend forecastJuly 2025 Outlook & AI Enhanced Trading Signals - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Published on: 2025-08-30 22:04:25 - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Is now a turning point for MannKind Corporation2025 Short Interest & Risk Adjusted Buy and Sell Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Full technical analysis of MannKind Corporation stockMarket Activity Report & Weekly Return Optimization Plans - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Using fundamentals and technicals on MannKind CorporationVolume Spike & AI Driven Stock Reports - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Does MannKind Corporation show high probability of reboundQuarterly Trade Report & Fast Moving Stock Watchlists - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

MannKind Buys scPharmaceuticals For $360 Million Bet: Can This Transform Its Future In Cardiorenal Care? - Smartkarma

Aug 30, 2025
pulisher
Aug 30, 2025

Has MannKind Corporation formed a bullish divergence2025 Technical Patterns & AI Driven Price Predictions - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Is MannKind Corporation stock reversal real or fakeWeekly Risk Report & Verified Entry Point Signals - Newser

Aug 30, 2025
pulisher
Aug 29, 2025

Does MannKind Corporation fit your quant trading model2025 Price Action Summary & Reliable Price Breakout Alerts - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

MannKind to acquire scPharmaceuticals stock in $303 million deal, H.C. Wainwright downgrades - Investing.com

Aug 29, 2025
pulisher
Aug 29, 2025

MannKind Corporation (MNKD) Seeks FDA Pediatric Approval for Afrezza - Insider Monkey

Aug 29, 2025

Mannkind Corp (MNKD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$24.87
price down icon 0.96%
$84.61
price up icon 1.09%
$23.70
price down icon 2.95%
$100.00
price down icon 1.89%
$136.10
price up icon 0.84%
biotechnology ONC
$306.05
price up icon 2.72%
大文字化:     |  ボリューム (24 時間):